Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Westerling

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Drugs|January 1, 1987
Aspects on the benefit-risk balance of felodipine in hypertensionD Elmfeldt, S Westerling
Journal of Cardiovascular Pharmacology|January 1, 1987
Felodipine in hypertension--a reviewD Elmfeldt, T Hedner, S Westerling
European Journal of Clinical Investigation|June 1, 1984
Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarctionP A Boström, J Andersson, B W Johansson, et al.
Lancet (London, England)|June 23, 1998
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupL Hansson, A Zanchetti, S G Carruthers, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Drugs|January 1, 1987
Aspects on the benefit-risk balance of felodipine in hypertensionD Elmfeldt, S Westerling
Journal of Cardiovascular Pharmacology|January 1, 1987
Felodipine in hypertension--a reviewD Elmfeldt, T Hedner, S Westerling
European Journal of Clinical Investigation|June 1, 1984
Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarctionP A Boström, J Andersson, B W Johansson, et al.
Lancet (London, England)|June 23, 1998
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupL Hansson, A Zanchetti, S G Carruthers, et al.
Pageof 1